These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

204 related articles for article (PubMed ID: 23736108)

  • 21. Association of angiotensin I-converting enzyme gene polymorphisms with aspirin intolerance in asthmatics.
    Kim TH; Chang HS; Park SM; Nam BY; Park JS; Rhim T; Park HS; Kim MK; Choi IS; Cho SH; Chung IY; Park BL; Park CS; Shin HD
    Clin Exp Allergy; 2008 Nov; 38(11):1727-37. PubMed ID: 18727619
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Dipeptidyl-peptidase 10 as a genetic biomarker for the aspirin-exacerbated respiratory disease phenotype.
    Kim SH; Choi H; Yoon MG; Ye YM; Park HS
    Ann Allergy Asthma Immunol; 2015 Mar; 114(3):208-13. PubMed ID: 25592153
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Genetic association analysis of CIITA variations with nasal polyp pathogenesis in asthmatic patients.
    Bae JS; Pasaje CF; Park BL; Cheong HS; Kim JH; Uh ST; Park CS; Shin HD
    Mol Med Rep; 2013 Mar; 7(3):927-34. PubMed ID: 23292525
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Safety of etoricoxib, a specific cyclooxygenase-2 inhibitor, in asthmatic patients with aspirin-exacerbated respiratory disease.
    El Miedany Y; Youssef S; Ahmed I; El Gaafary M
    Ann Allergy Asthma Immunol; 2006 Jul; 97(1):105-9. PubMed ID: 16892790
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Mediator release after nasal aspirin provocation supports different phenotypes in subjects with hypersensitivity reactions to NSAIDs.
    Campo P; Ayuso P; Salas M; Plaza MC; Cornejo-García JA; Doña I; Torres MJ; Blanca-López N; Canto G; Guéant JL; Sanak M; Blanca M
    Allergy; 2013 Aug; 68(8):1001-7. PubMed ID: 23889565
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Potential association of DDR1 genetic variant with FEV1 decline by aspirin provocation in asthmatics.
    Kim JY; Kim JH; Park BL; Pasaje CF; Bae JS; Uh ST; Kim YH; Kim MK; Choi IS; Cho SH; Choi BW; Park JS; Park CS; Shin HD
    J Asthma; 2012 Apr; 49(3):237-42. PubMed ID: 22380734
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Association of TRPM3 Polymorphism (rs10780946) and Aspirin-Exacerbated Respiratory Disease (AERD).
    Narayanankutty A; Palma-Lara I; Pavón-Romero G; Pérez-Rubio G; Camarena Á; Teran LM; Falfán-Valencia R
    Lung; 2016 Apr; 194(2):273-9. PubMed ID: 26891941
    [TBL] [Abstract][Full Text] [Related]  

  • 28. CD55 polymorphisms and risk of aspirin‑exacerbated respiratory disease.
    Lee JS; Bae JS; Kim JH; Kim JY; Park TJ; Pasaje CF; Park BL; Cheong HS; Uh ST; Jang AS; Choi IS; Park CS; Shin HD
    Mol Med Rep; 2012 Nov; 6(5):1087-92. PubMed ID: 22961402
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Genetic variability in CRTH2 polymorphism increases eotaxin-2 levels in patients with aspirin exacerbated respiratory disease.
    Palikhe NS; Kim SH; Cho BY; Ye YM; Choi GS; Park HS
    Allergy; 2010 Mar; 65(3):338-46. PubMed ID: 19796209
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Genome-wide association study of aspirin-exacerbated respiratory disease in a Korean population.
    Park BL; Kim TH; Kim JH; Bae JS; Pasaje CF; Cheong HS; Kim LH; Park JS; Lee HS; Kim MS; Choi IS; Choi BW; Kim MK; Shin S; Shin HD; Park CS
    Hum Genet; 2013 Mar; 132(3):313-21. PubMed ID: 23180272
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Association of three sets of high-affinity IgE receptor (FcepsilonR1) polymorphisms with aspirin-intolerant asthma.
    Palikhe NS; Kim SH; Cho BY; Ye YM; Hur GY; Park HS
    Respir Med; 2008 Aug; 102(8):1132-9. PubMed ID: 18595682
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Safety of parecoxib in asthmatic patients with aspirin-exacerbated respiratory disease.
    Valero A; Sánchez-López J; Bartra J; Serrano C; Muñoz-Cano R; Roca J; Picado C
    Int Arch Allergy Immunol; 2011; 156(2):221-3. PubMed ID: 21597303
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Failure of tacrolimus to prevent aspirin-induced respiratory reactions in patients with aspirin-exacerbated respiratory disease.
    Stevenson DD; Mehra PK; White AA; Gupta S; Woessner KM; Simon RA
    J Allergy Clin Immunol; 2005 Oct; 116(4):755-60. PubMed ID: 16210047
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Single nucleotide polymorphisms in TNF are associated with susceptibility to aspirin-exacerbated respiratory disease but not to cytokine levels: a study in Mexican mestizo population.
    Pavón-Romero GF; Reséndiz-Hernández JM; Ramírez-Jiménez F; Pérez-Rubio G; Camarena Á; Terán LM; Falfán-Valencia R
    Biomark Med; 2017 Dec; 11(12):1047-1055. PubMed ID: 29172674
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Platelet activation markers overexpressed specifically in patients with aspirin-exacerbated respiratory disease.
    Mitsui C; Kajiwara K; Hayashi H; Ito J; Mita H; Ono E; Higashi N; Fukutomi Y; Sekiya K; Tsuburai T; Akiyama K; Yamamoto K; Taniguchi M
    J Allergy Clin Immunol; 2016 Feb; 137(2):400-11. PubMed ID: 26194538
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Association analysis of RGS7BP gene polymorphisms with aspirin intolerance in asthmatic patients.
    Lee EH; Park BL; Park SM; Lee SH; Park SW; Park JS; Uh ST; Kim MK; Choi IS; Cho SH; Hong CS; Lee JY; Choi BW; Shin HD; Park CS
    Ann Allergy Asthma Immunol; 2011 Apr; 106(4):292-300.e6. PubMed ID: 21457877
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Safety of high-dose rofecoxib in patients with aspirin-exacerbated respiratory disease.
    Woessner KM; Simon RA; Stevenson DD
    Ann Allergy Asthma Immunol; 2004 Oct; 93(4):339-44. PubMed ID: 15521369
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Factors associated with asthma control in patients with aspirin-exacerbated respiratory disease.
    Bochenek G; Szafraniec K; Kuschill-Dziurda J; Nizankowska-Mogilnicka E
    Respir Med; 2015 May; 109(5):588-95. PubMed ID: 25820158
    [TBL] [Abstract][Full Text] [Related]  

  • 39. HLA-DRA polymorphisms associated with risk of nasal polyposis in asthmatic patients.
    Kim JH; Park BL; Cheong HS; Pasaje CF; Bae JS; Park JS; Uh ST; Kim YH; Kim MK; Choi IS; Choi BW; Park CS; Shin HD
    Am J Rhinol Allergy; 2012; 26(1):12-7. PubMed ID: 22391069
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Genetic association analysis of TAP1 and TAP2 polymorphisms with aspirin exacerbated respiratory disease and its FEV1 decline.
    Kim JH; Park BL; Pasaje CF; Bae JS; Park JS; Park SW; Uh ST; Kim MK; Choi IS; Cho SH; Choi BW; Park CS; Shin HD
    J Hum Genet; 2011 Sep; 56(9):652-9. PubMed ID: 21796142
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.